Table 2 Demographic and clinical data of diabetic subjects with and without PAD
|  | WPAD (n  =  300) | PAD (n  =  300) | P value |
|---|---|---|---|
ABI (years  ±  SD) | 1.12  ±  0.5 | 0.67  ±  0.3 | 0.009 |
Men/female (n) | 199:101 | 210:90 | 0.66 |
Age (years  ±  SD) | 73.2  ±  9.1 | 76.1  ±  5.1 | 0.19 |
BMI (kg/m2) | 26.2 ± 3.1 | 25.6 ± 4.2 | 0.83 |
Smoking (current) (%) | 84 (28.0) | 156 (52.0) | 0.011 |
Hypertension (%) | 158 (52.6) | 201 (67.0) | 0.010 |
CAD (%) | 101 (33.6) | 186 (62.0) | 0.022 |
Heart failure (%) | 33 (11.0) | 38 (12.7) | 0.82 |
Diabetes duration (years  ±  SD) | 10.1  ±  2.1 | 11.3  ±  4.1 | 0.48 |
Total cholesterol (mmol/l) | 5.54 (1.12) | 5.98 (1.28) | 0.78 |
HDL-C (mmol/l) | 1.41 (1.13) | 1.31 (1.14) | 0.59 |
LDL-C (mmol/l) | 2.13 (1.22) | 2.97 (1.23) | 0.02 |
Triglyceride (mmol/l) | 2.12 (1.42) | 2.33 (1.47) | 0.78 |
Fasting glucose (mmol/l) | 7.22 (1.13) | 7.22 (1.43) | 0.76 |
Glycated hemoglobin (%) | 7.18 (1.87) | 7.94 (1.87) | 0.76 |
eGFR (ml/min per 1.73 m2) | 69.23 (11.03) | 65.92 (9.12) | 0.32 |
Treatment | |||
  Diet only (%) | 44 (14.6) | 31 (10.3) | 0.36 |
  Oral agents (%) | 164 (54.6) | 175 (58.3) | 0.87 |
  Insulin therapy (%) | 92 (30.6) | 125 (41.6) | 0.12 |
PAD | |||
  1-Fontaine’s II (%) |  | 168 (56.0) |  |
  2-Fontaine’s III (%) |  | 72 (24.0 |  |
  2-Fontaine’s IV (%) |  | 60 (20.0) |  |